Novo Nordisk
NVO
$107.75
Share price
3.56%
Change (1 day)
33.30%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Market capitalization of Novo Nordisk (NVO)
Market cap: $244.30 Billion
As of May 2022 Novo Nordisk has a market cap of $244.30 Billion. This makes Novo Nordisk the world's 32th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Novo Nordisk from 2001 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $244.30 B | -4.22% |
| 2021 | $255.07 B | 56.42% |
| 2020 | $163.07 B | 17.22% |
| 2019 | $139.12 B | 24.43% |
| 2018 | $111.80 B | -14.74% |
| 2017 | $131.12 B | 39.24% |
| 2016 | $94.17 B | -38.17% |
| 2015 | $152.30 B | 35.23% |
| 2014 | $112.62 B | 11.3% |
| 2013 | $101.18 B | 11.24% |
| 2012 | $90.96 B | 36.37% |
| 2011 | $66.70 B | -1.24% |
| 2010 | $67.54 B | 66.85% |
| 2009 | $40.48 B | 24.25% |
| 2008 | $32.58 B | -22.36% |
| 2007 | $41.96 B | 58.17% |
| 2006 | $26.53 B | 45.63% |
| 2005 | $18.21 B | 1.1% |
| 2004 | $18.02 B | 27.41% |
| 2003 | $14.14 B | 40.56% |
| 2002 | $10.06 B | -27.62% |
| 2001 | $13.90 B |
End of Day market cap according to different sources
On May 20th, 2022 the market cap of Novo Nordisk was reported to be:
$247.84 Billion
$247.84 Billion
$244.30 Billion
$190.99 Billion
$183.54 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $294.40 B | 20.51% | 🇺🇸 USA |
 Eli Lilly LLY | $283.95 B | 16.23% | 🇺🇸 USA |
 Sanofi SNY | $135.85 B | -44.39% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $162.21 B | -33.60% | 🇺🇸 USA |